Follow
Ludwig Dubois
Ludwig Dubois
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
KMA Rouschop, T van den Beucken, L Dubois, H Niessen, J Bussink, ...
The Journal of clinical investigation 120 (1), 127-141, 2010
9112010
Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET
HJWL Aerts, L Dubois, L Perk, P Vermaelen, GAMS van Dongen, ...
Journal of Nuclear Medicine 50 (1), 123-131, 2009
2502009
PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS
KM Rouschop, LJ Dubois, TG Keulers, T van den Beucken, P Lambin, ...
Proceedings of the National Academy of Sciences 110 (12), 4622-4627, 2013
2372013
Tracking tumor biology with radiomics: a systematic review utilizing a radiomics quality score
S Sanduleanu, HC Woodruff, EEC De Jong, JE Van Timmeren, ...
Radiotherapy and Oncology 127 (3), 349-360, 2018
2332018
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ...
Mutation Research/Reviews in Mutation Research 764, 16-30, 2015
2152015
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ...
Radiotherapy and Oncology 99 (3), 424-431, 2011
2122011
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model
L Dubois, NG Lieuwes, A Maresca, A Thiry, CT Supuran, A Scozzafava, ...
Radiotherapy and Oncology 92 (3), 423-428, 2009
2102009
Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies
P Ebbesen, EO Pettersen, TA Gorr, G Jobst, K Williams, J Kieninger, ...
Journal of enzyme inhibition and medicinal chemistry 24 (sup1), 1-39, 2009
2062009
A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model
SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ...
International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015
2012015
Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?
V Sosa Iglesias, L Giuranno, LJ Dubois, J Theys, M Vooijs
Frontiers in oncology 8, 267, 2018
1902018
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors
L Dubois, K Douma, CT Supuran, RK Chiu, MAMJ van Zandvoort, ...
Radiotherapy and oncology 83 (3), 367-373, 2007
1762007
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
J Theys, O Pennington, L Dubois, G Anlezark, T Vaughan, A Mengesha, ...
British journal of cancer 95 (9), 1212-1219, 2006
1672006
Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis
SJA van Kuijk, A Yaromina, R Houben, R Niemans, P Lambin, LJ Dubois
Frontiers in oncology 6, 69, 2016
1612016
Decision support systems for personalized and participative radiation oncology
P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ...
Advanced drug delivery reviews 109, 131-153, 2017
1592017
Preclinical evaluation and validation of [18F] HX4, a promising hypoxia marker for PET imaging
LJ Dubois, NG Lieuwes, MHM Janssen, WJM Peeters, AD Windhorst, ...
Proceedings of the National Academy of Sciences 108 (35), 14620-14625, 2011
1562011
Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells
KM Panth, RTH Leijenaar, S Carvalho, NG Lieuwes, A Yaromina, ...
Radiotherapy and Oncology 116 (3), 462-466, 2015
1442015
Evaluation of hypoxia in an experimental rat tumour model by [18F] fluoromisonidazole PET and immunohistochemistry
L Dubois, W Landuyt, K Haustermans, P Dupont, G Bormans, ...
British journal of cancer 91 (11), 1947-1954, 2004
1402004
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
EO Pettersen, P Ebbesen, RG Gieling, KJ Williams, L Dubois, P Lambin, ...
Journal of enzyme inhibition and medicinal chemistry 30 (5), 689-721, 2015
1342015
PET imaging of hypoxia using [18F]HX4: a phase I trial
J van Loon, MHM Janssen, M Öllers, HJWL Aerts, L Dubois, ...
European journal of nuclear medicine and molecular imaging 37, 1663-1668, 2010
1292010
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ...
Clinical cancer research 21 (13), 2984-2992, 2015
1242015
The system can't perform the operation now. Try again later.
Articles 1–20